3 studies found for:    "methodist hospital" | Open Studies | "Lymphoma, B-Cell" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
Conditions: B Cell Lymphoma;   Chronic Lymphocytic Leukemia
Interventions: Genetic: CD19CAR-28-zeta T cells;   Drug: Ipilimumab
2 Recruiting Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
Conditions: Lymphoma;   Myeloma;   Leukemia
Intervention: Biological: Kappa CD28 T cells
3 Recruiting Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL and CLL (SAGAN)
Conditions: Non-Hodgkin Lymphoma;   Chronic Lymphocytic Leukemia
Intervention: Biological: CD19 Specific CAR T Cells

Indicates status has not been verified in more than two years